What Does the FDA Say About CBD Testing?

Cannabidiol (CBD) is a compound found in cannabis plants that has been gaining popularity in recent years. With its increasing use, many people have been wondering if CBD is tested by the Food and Drug Administration (FDA). The answer is yes, the FDA has conducted tests on CBD products to ensure their safety and accuracy. The FDA has tested the chemical content of cannabinoid compounds in some of the products and found that many did not contain the levels of CBD they claimed.

This has led to the agency issuing warning letters to companies for selling products labeled as containing CBD in a way that violates the Federal Food, Drug and Cosmetic Act (FD&C Act). The FDA has also expressed concern about CBD products marketed to food-producing animals and possible safety issues related to food products for human use. In addition, there are many unanswered questions about the science, safety, and quality of products containing CBD. The FDA has not approved any CBD product other than a prescription drug for human use to treat rare and serious forms of epilepsy.

It has also warned companies to stop selling CBD products that they claim are intended to prevent, diagnose, treat, mitigate or cure serious diseases such as cancer, Alzheimer's disease, psychiatric disorders and diabetes. The FDA has not approved any over-the-counter (OTC) drugs containing CBD, and none of these products meet the requirements to be legally marketed without a new approved drug application. However, changes in the law could result in a more simplified process for researchers to study cannabis and its derivatives, including CBD. In conclusion, it is important to note that the FDA has conducted tests on CBD products to ensure their safety and accuracy. The agency has also issued warning letters to companies for selling products labeled as containing CBD in a way that violates the FD&C Act.

It is also important to remember that the FDA has not approved any other cannabis product, derived from cannabis or cannabidiol (CBD) currently available on the market.